Contact Us Careers Register
Coherent Market Insights

Mental Disorder Treatment Market to Surpass US$ 75.7 Billion by 2027

Mental Disorder Treatment Market to Surpass US$ 75.7 Billion by 2027 - Coherent Market Insights

Publish In : Dec 23, 2020

Report ID : CMI4326

Category : Pharmaceutical

Mental Disorder Treatment Market to Surpass US$ 75.7 Billion by 2027

Global Mental Disorder Treatment Market, by Disorder Type (Depression, Bipolar Disorder, Schizophrenia, Dementia, Post-traumatic Stress Disorder, and Others), by Medication  (Anti-depressants, Anti-anxiety, Mood Stabilizing Medication, and Antipsychotic Medications), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 48.4 billion in 2020 and is expected to exhibit a CAGR of 6.6 % during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

Major companies focusing on product approvals for the treatment of mental disorders is expected to drive the growth of mental disorder treatment market. For instance, in August 2020, Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) approved SPRAVATO (esketamine) CIII nasal spray, as a supplemental new drug application (sNDA). SPRAVATO (esketamine) CIII nasal spray is indicated to treat depressive symptoms in adults with major depressive disorder (MDD) and acute suicidal behavior.

Global Mental Disorder Treatment Market – Impact of Coronavirus (COVID-19)

  • The COVID-19 pandemic has drastically impacted each and every market across the world. Therefore, government agencies are taking initiatives to know the effect of pandemic on the mental health. For instance, on November 18, 2020, Himachal Pradesh State Mental Health Authority, India, announced that they are going to start mental health survey collaborating with the Department of Psychology, University of Himachal Pradesh. Under this survey, the researchers will assess the impact of pandemic on mental health of individuals, and will conduct the survey in Himachal Pradesh, India, with sample size of around 75,000 individuals.
  • Moreover, the COVID-19 pandemic has affected the global mental disorder treatment market in three main ways; by directly affecting the production and demand; by creating disruptions in distribution channels; and by its financial impact on firms and financial markets. Supply chain and manufacturing activities in India, China, and the U.S. are disrupted due to nationwide lockdowns. Whereas, countries such as Saudi Arabia, UAE, Egypt, and others are facing problems due to transportation of drugs from one place to another.

Browse 33 Market Data Tables and 32 Figures spread through 175  Pages and in-depth TOC on “Global Mental Disorder Treatment Market, by Disorder Type (Depression, Bipolar Disorder, Schizophrenia, Dementia, Post-traumatic Stress Disorder, and Others), by Medication (Anti-depressants, Anti-anxiety, Mood Stabilizing Medication, and Antipsychotic Medications), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa

To know the latest trends and insights prevalent in the global mental disorder treatment market, click the link below:

https://www.coherentmarketinsights.com/market-insight/mental-disorder-treatment-market-4326

The global mental disorder treatment market is expected to witness significant growth during the forecast period, owing to increasing prevalence of mental disorders such as Schizophrenia globally. For instance, according to the World Health Organization report published in 2019, stated that around 20 million individuals suffered from Schizophrenia disorder globally, in the year 2019.

Moreover, increasing prevalence of mental disorders such as dementia and developmental disorders, including autism is expected to drive growth of global mental disorder treatment market. For instance, according to the World Health Organization report published in 2019, stated that around 50 million individuals suffered from dementia globally, in the year 2019.

Key Takeaways of the Global mental disorder treatment Market:

  • The global mental disorder treatment market is expected to exhibit a CAGR of 6.6 % during the forecast period, owing to key companies focusing on product launches for the treatment of mental disorders such as bipolar disorders, depression, and others. For instance, in 2019, Sun Pharmaceutical Industries recently announced the launched of Drizalma Sprinkle (duloxetine delayed-release capsules) in the U.S. for oral use. Drizalma Sprinkle is a serotonin and norepinephrine reuptake inhibitor (SNRI) designed for the treatment of various neuro-psychiatric and pain disorders in patients who have difficulty swallowing.
  • https://business.medicaldialogues.in/sun-pharma-launches-drizalma-sprinkle-in-us-for-treating-neuro-psychiatric-and-pain-disorders-in-patients-with-swallowing-difficulties?infinitescroll=1
  • Among disorder type, depression segment is estimated to hold major market share in the global mental disorder treatment market during the forecast period, owing to increasing prevalence of depression in individuals globally.
  • Among medication, anti-depressants segment is estimated to hold major market share in the global mental disorder treatment market during the forecast period, owing to rising incidence of depression in children and adults globally. According to Center of Disease Control and Prevention report published in 2019, stated that approximately 9.3% of children were suffering from mental disorders such as depression in US, in 2019.
  • Key players operating in the global mental disorder treatment market include Allergan plc., Eli Lilly and Company, VistaGen Therapeutics, Sanofi S.A, Novartis International AG, Mylan N.V., Amneal Pharmaceuticals LLC, Cipla Ltd, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Limited, Lupin Limited, Janssen Pharmaceutica, Bristol Myers Squibb, and Sumitomo Dainippon Pharma Co., Ltd

ABOUT US:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

CONTACT US:

Mr. Shah

Senior Client Partner – Business Development

Coherent Market Insights

PHONE:

UK: +44-203-957-8553 / +44-203-949-5508

US: +1-252-477-1362

AUS: +61-8-7924-7805

INDIA: +91-848-285-0837

Email: [email protected]

Follow Us: LinkedIn | Twitter

Need more?

Speak to our analyst to understand how this research was put together
Add more segments or countries to the scope as part of free customization
Understand how this report can have a direct impact on your revenue

  • Supplier Analysis
  • Value Chain Analysis
  • Demand Analysis
  • Customer Intelligence
  • Trade Analysis
  • Pricing Analysis

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports


Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Created billion dollars of revenue impact on thousands of clients

trusted clients logo

LogoCredibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

Reliability and Reputation

860519526

Reliability and Reputation
ISO 9001:2015

9001:2015

ISO 27001:2022

27001:2022

Reliability and Reputation
Reliability and Reputation
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.
Enquiry Icon Contact Us